Welcome to In-Tech. In today’s episode we’ll be diving into the Coronavirus, or in this case, how to detect it.
The title doesn’t lie. The developers at the American company, Advanced Medical Solutions International (AMSI), claim that their scanner will be able to detect Coronavirus in people and surfaces. The world’s first non-contact viral detector, aptly named Covid Hunter, can identify traces of Coronavirus from as far as 2 meters away, even behind plastic or thin glass. It can also identify new strains of the COVID-19 virus and other viruses, such as influenza, AMSI reported in a statement.
“The Covid Hunter is a non-invasive, non-contact, immediate and portable virus detector, specially designed for the SARS-CoV-2 virus that causes covid-19 disease, demonstrating 99% effectiveness and with sensitivity within 0 to 2 meters on surfaces, through glass or transparent material , and inside the human body ” claimed the company.
They also explained that the Covid Hunter will be able to locate traces of the Coronavirus in human organs, such as the lungs, throat, nose and skin, and even on clothing. Simply point the scanner at the object and start scanning. It emits a beam just like any other laser scanner, but it simultaneously transmits data into its software to analyze in real time, by refraction, if the spike protein of the SARS-CoV-2 virus is present. When the Covid Hunter detects this protein, or any characteristics of the coronavirus, it emits an alarm, and if there is no presence of the virus, it remains silent.
Dr. Alejandro Diaz Villalobos explained that the Covid Hunter scanner has a 100% efficiency rate in all the tests conducted by the team. Dr. Villalobos believes that prevention would be the best way to contain the pandemic since it will take time for the vaccine to be applied to all of the world’s population. Dr. Diaz stated that “If we can immediately detect who is infected, we can mitigate their contact with other people or control their access”
The Covid Hunter will be Made in Mexico. The doctor hopes “to have the first production prototype in three weeks.” They anticipate that when the first production is carried out, they will be able to get certification from health authorities, such as the FDA in the United States and Cofepris in Mexico.